Sheetal Ayurved Bhandar Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.46 M
- Revenue Growth 14.57%
- Profit Growth -21.31%
- Ebitda -40.46%
- Net Worth 12.97%
- Total Assets -15.71%
About Sheetal Ayurved Bhandar
Sheetal Ayurved Bhandar Private Limited (SABPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 December 2005 and has a history of 19 years and one month. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.46 M.
Kalpana Pandya and Beena Pandya serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85191MH2005PTC158146
-
Company No.
158146
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Dec 2005
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Sheetal Ayurved Bhandar?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalpana Pandya
|
Director | 25-Mar-2015 | Current |
|
Beena Pandya
|
Director | 10-Jan-2022 | Current |
Financial Performance of Sheetal Ayurved Bhandar.
Sheetal Ayurved Bhandar Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 14.57% increase. The company also saw a substantial fall in profitability, with a 21.31% decrease in profit. The company's net worth Soared by an impressive increase of 12.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sheetal Ayurved Bhandar?
In 2020, Sheetal Ayurved Bhandar had a promoter holding of 51.00% and a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.46 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Oct 2017 | Others | ₹0.46 M | Open |
How Many Employees Work at Sheetal Ayurved Bhandar?
Unlock and access historical data on people associated with Sheetal Ayurved Bhandar, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sheetal Ayurved Bhandar, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sheetal Ayurved Bhandar's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
